Literature DB >> 2847277

[Study of antiglycolipid antibodies in IgM monoclonal dysglobulinemias associated with peripheral neuropathy].

M O Jauberteau1, D Henin, P Bouche, J M Vallat, M Dumas, S Dellagi, J M Leger, M L Harpin, H Ratinahirana, M P Chaunu.   

Abstract

An immunological mechanism may be responsible for the peripheral neuropathies related to IgM monoclonal gammopathies. Myelin-associated glycoprotein (MAG) has been found to be one the main target antigens for these paraproteinemias. Glycosphingolipids of peripheral nerve have been also found to be targets for these antibodies, especially a sulfated glycosphingolipid containing glucuronic acid (GLSG) specific for peripheral nerve. Crossed reactivity has been found between MAG and GLSG. Anti-glycolipid antibodies were determined in 14 patients with IgM gammopathy and polyneuropathy. Glycosphingolipids from human peripheral nerve were purified and chromatographed by thin-layer chromatography for immunodetection of the antibodies. The 12 patients who had GLSG antibody activity had a clinical status identical to the reported cases of dysglobulinemic neuropathies with anti-MAG antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847277

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  9 in total

Review 1.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.

Authors:  X Mariette; C Chastang; P Clavelou; J P Louboutin; J M Leger; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

3.  Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.

Authors:  A Vital; C Vital; J Julien; A Baquey; A J Steck
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Morphological changes in IgM paraproteinaemic neuropathy.

Authors:  J M Jacobs; J W Scadding
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 5.  Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy.

Authors:  J M Leger; A B Younes-Chennoufi; B Chassande; G Davila; P Bouche; N Baumann; P Brunet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

6.  Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.

Authors:  M O Jauberteau; N Gualde; J L Preud'Homme; M Rigaud; R Gil; J M Vallat; N Baumann
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study.

Authors:  J M Léger; A B Younes-Chennoufi; M Zuber; P Bouche; M O Jauberteau; D Dormont; F Danon; N Baumann; P Brunet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

8.  Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy.

Authors:  B Lach; P Rippstein; D Atack; D E Afar; A Gregor
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group.

Authors:  E Oksenhendler; S Chevret; J M Léger; J P Louboutin; A Bussel; J C Brouet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.